Skip to main content
Top
Published in: Clinical Rheumatology 5/2021

Open Access 01-05-2021 | Mood Disorders | Original Article

Impact of clinical and psychological factors associated with depression in patients with rheumatoid arthritis: comparative study between Germany and Brazil

Authors: Harriet Morf, Geraldo da Rocha Castelar-Pinheiro, Ana Beatriz Vargas-Santos, Christoph Baerwald, Olga Seifert

Published in: Clinical Rheumatology | Issue 5/2021

Login to get access

Abstract

Objective

To investigate the prevalence of depressive symptoms and its association with clinical and psychological factors in patients with rheumatoid arthritis (RA) in Germany and in Brazil.

Method

A convenience sample of 267 RA patients, 176 from Germany (age 62.4 ± 12.3 years) and 91 from Brazil (age 56.3 ± 12.6 years), was used in this cross-sectional study. The following questionnaires were used: Beck Depression Inventory (BDI), painDETECT test, Perceived Stress Questionnaire, fatigue questionnaire (FACIT), Health Assessment Questionnaire Disability Index (HAQ-DI), and the SF–36 questionnaires (Short-Form 36 Health Survey). Disease activity score (DAS 28-CRP) and visual analogue scale (VAS) for pain were also evaluated. Statistical analysis is based on comparison of means and proportions. Statistical significance for non-normal data was evaluated by non-parametrical tests.

Results

Depressive symptoms were more prevalent in the Brazilian sample (44% vs 22.9%, p = 0.025). Compared to German patients, the Brazilian ones also experienced more pain (current pain status on VAS: 4.67 ± 3.4 vs 3.67 ± 2.31 respectively, p < 0.01), were physically more limited (1.89 ± 1.85 vs 1.01 ± 0.75, p = 0.012), and had higher C-reactive protein levels (7.78 ± 18.3 vs 5.82 ± 10.45, p = 0.028). Despite receiving a more intensive treatment, German patients presented similar disease activity when compared to Brazilian patients (DAS28-CRP: Brazil 3.4 ± 1.5 vs Germany 3.3 ± 1.3, p = 0.307).

Conclusion

Depressive symptoms are frequent in RA patients from different countries and interact with psychological disorders and the experience of pain. They contribute negatively to their well-being suggesting the need for psychoeducational strategies.
Key Points
New psychoeducational strategies for RA management.Higher inflammation marker in rheumatoid arthritis patients is associated with depression.Medical treatment in RA influences depressive symptoms.Depressive symptoms are dependent on population group.High disease activity is related to depression.
Literature
1.
go back to reference Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038CrossRef Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet 388(10055):2023–2038CrossRef
2.
go back to reference Krasselt M, Baerwald C (2017) Sex, symptom severity, and quality of life in rheumatology. Clin Rev Allergy Immunol 9:1–16 Krasselt M, Baerwald C (2017) Sex, symptom severity, and quality of life in rheumatology. Clin Rev Allergy Immunol 9:1–16
3.
go back to reference Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188CrossRef Alamanos Y, Voulgari PV, Drosos AA (2006) Incidence and prevalence of rheumatoid arthritis based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 36(3):182–188CrossRef
4.
go back to reference David JM, Mattei RA, Mauad JL, de Almeida LG, Nogueira MA, Menolli PV, Menolli RA (2013) Clinical and laboratory features of patients with rheumatoid arthritis diagnosed at rheumatology services in the Brazilian municipality of Cascavel, PR, Brazil. Rev Bras Reumatol 53(1):57–65PubMed David JM, Mattei RA, Mauad JL, de Almeida LG, Nogueira MA, Menolli PV, Menolli RA (2013) Clinical and laboratory features of patients with rheumatoid arthritis diagnosed at rheumatology services in the Brazilian municipality of Cascavel, PR, Brazil. Rev Bras Reumatol 53(1):57–65PubMed
5.
go back to reference Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Flacke JP, Fliedner G, Henkemeier U, Hofmann MW, Kleinert S, Kneitz C, Krüger K, Pohl C, Schett G, Schmalzing M, Tausche AK, Tony HP, Wendler J (2019) New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - implications from the prospective multicenter VADERA II study. PLoS One 14(5):e0217412CrossRef Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Flacke JP, Fliedner G, Henkemeier U, Hofmann MW, Kleinert S, Kneitz C, Krüger K, Pohl C, Schett G, Schmalzing M, Tausche AK, Tony HP, Wendler J (2019) New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - implications from the prospective multicenter VADERA II study. PLoS One 14(5):e0217412CrossRef
6.
go back to reference Sheehy C, Murphy E, Barry M (2006) Depression in rheumatoid arthritis- underscoring the problem. Rheumatology (Oxford) 45(11):1325–1327CrossRef Sheehy C, Murphy E, Barry M (2006) Depression in rheumatoid arthritis- underscoring the problem. Rheumatology (Oxford) 45(11):1325–1327CrossRef
7.
go back to reference Mella LF, Bértolo MB, Dalgalarrondo P (2010) Depressive symptoms in rheumatoid arthritis. Rev Bras Psiquiatr 32(3):257–263CrossRef Mella LF, Bértolo MB, Dalgalarrondo P (2010) Depressive symptoms in rheumatoid arthritis. Rev Bras Psiquiatr 32(3):257–263CrossRef
8.
go back to reference Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, Tennant A (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS). BMC Psychiatry 12:6CrossRef Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, Tennant A (2012) Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS). BMC Psychiatry 12:6CrossRef
9.
go back to reference Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, el-zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo S-F, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song Y-W, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68CrossRef Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, el-zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo S-F, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song Y-W, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68CrossRef
10.
go back to reference Overman CL, Jurgens MS, Bossema ER, Jacobs JW, Bijlsma JW, Geenen R (2014) Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades. Arthritis Care Res (Hoboken). 66(5):671–678CrossRef Overman CL, Jurgens MS, Bossema ER, Jacobs JW, Bijlsma JW, Geenen R (2014) Change of psychological distress and physical disability in patients with rheumatoid arthritis over the last two decades. Arthritis Care Res (Hoboken). 66(5):671–678CrossRef
11.
go back to reference Nerurkar L, Siebert S, McInnes IB, Cavanagh J (2018) Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiat 6(2):164–173 Nerurkar L, Siebert S, McInnes IB, Cavanagh J (2018) Rheumatoid arthritis and depression: an inflammatory perspective. Lancet Psychiat 6(2):164–173
12.
go back to reference Gåfvels C, Hägerström M, Nordmark B, Wändell PE (2012) Psychosocial problems among newly diagnosed rheumatoid arthritis patients. Clin Rheumatol 31(3):521–529CrossRef Gåfvels C, Hägerström M, Nordmark B, Wändell PE (2012) Psychosocial problems among newly diagnosed rheumatoid arthritis patients. Clin Rheumatol 31(3):521–529CrossRef
13.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology /European league against rheumatism collaborative initiative. Arthritis Rheumatol 62(9):2569–2581CrossRef Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) Rheumatoid arthritis classification criteria: an American College of Rheumatology /European league against rheumatism collaborative initiative. Arthritis Rheumatol 62(9):2569–2581CrossRef
14.
go back to reference Bruce B, Fries JF (2005) The health assessment questionnaire (HAQ). Clin Exp Rheumatol 23:S14–S18PubMed Bruce B, Fries JF (2005) The health assessment questionnaire (HAQ). Clin Exp Rheumatol 23:S14–S18PubMed
15.
go back to reference Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-2. Psychological Corporation, San Antonio Beck AT, Steer RA, Brown GK (1996) Manual for the Beck Depression Inventory-2. Psychological Corporation, San Antonio
16.
go back to reference Krug HE, Woods SR, Mahowald ML (1997) The importance of identifying depression in patients with rheumatoid arthritis: evaluation of the beck depression inventory. J Clin Rheumatol 3(5):248–257CrossRef Krug HE, Woods SR, Mahowald ML (1997) The importance of identifying depression in patients with rheumatoid arthritis: evaluation of the beck depression inventory. J Clin Rheumatol 3(5):248–257CrossRef
17.
go back to reference McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66CrossRef McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD (1994) The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32(1):40–66CrossRef
18.
go back to reference Freynhagen R, Baron R, Gockel U, Tölle TR (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22(10):1911–1920CrossRef Freynhagen R, Baron R, Gockel U, Tölle TR (2006) painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 22(10):1911–1920CrossRef
19.
go back to reference Faro A (2015) Analise Fatorial Confirmatoria das Tres Versoes da perceived stress scale (PSS): um Estudo Populacional. Psychol/Psicol Reflexao Crit 28(1):21–30CrossRef Faro A (2015) Analise Fatorial Confirmatoria das Tres Versoes da perceived stress scale (PSS): um Estudo Populacional. Psychol/Psicol Reflexao Crit 28(1):21–30CrossRef
20.
go back to reference Spielberger CD (1996) Preliminary manual for the state-trait personality inventory. University of South Florida, Tampa Spielberger CD (1996) Preliminary manual for the state-trait personality inventory. University of South Florida, Tampa
21.
go back to reference Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW (2003) Item banking to improve, shorten and computerized self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-fatigue scale. Qual Life Res 12(5):485–501CrossRef Lai JS, Cella D, Chang CH, Bode RK, Heinemann AW (2003) Item banking to improve, shorten and computerized self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-fatigue scale. Qual Life Res 12(5):485–501CrossRef
22.
go back to reference Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52(12):2136–2148CrossRef Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52(12):2136–2148CrossRef
23.
go back to reference Phillips K, J Clauw D (2013) Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum 65(2): 291–302 Phillips K, J Clauw D (2013) Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum 65(2): 291–302
24.
go back to reference Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 45(7):885–889CrossRef Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 45(7):885–889CrossRef
25.
go back to reference Morete MC, Solano JPC, Boff MS, Filho WJ, Ashmawi HA (2018) Resilience, depression, and quality of life in elderly individuals with chronic pain followed up in an outpatient clinic in the city of São Paulo, Brazil. J Pain Res 11:2561–2566CrossRef Morete MC, Solano JPC, Boff MS, Filho WJ, Ashmawi HA (2018) Resilience, depression, and quality of life in elderly individuals with chronic pain followed up in an outpatient clinic in the city of São Paulo, Brazil. J Pain Res 11:2561–2566CrossRef
26.
go back to reference Cheon YH, Lee SG, Kim M, Kim HO, Sun Suh Y, Park KS, Kim RB, Yang HS, Kim JM, Son CN, Kyoung Park E, Kim SH, Lee SI (2018) The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis. Brain Behav Immun 73:274–281CrossRef Cheon YH, Lee SG, Kim M, Kim HO, Sun Suh Y, Park KS, Kim RB, Yang HS, Kim JM, Son CN, Kyoung Park E, Kim SH, Lee SI (2018) The association of disease activity, pro-inflammatory cytokines, and neurotrophic factors with depression in patients with rheumatoid arthritis. Brain Behav Immun 73:274–281CrossRef
30.
go back to reference Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S, Galloway J (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 57(5):835–843CrossRef Matcham F, Davies R, Hotopf M, Hyrich KL, Norton S, Steer S, Galloway J (2018) The relationship between depression and biologic treatment response in rheumatoid arthritis: an analysis of the British Society for Rheumatology Biologics Register. Rheumatology (Oxford) 57(5):835–843CrossRef
31.
go back to reference Miwa Y, Ikari Y, Hosonuma M, Hatano M, Hayashi T, Kasama T, Sanada K (2018) A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment. Eur J Rheumatol 5(2):111–114CrossRef Miwa Y, Ikari Y, Hosonuma M, Hatano M, Hayashi T, Kasama T, Sanada K (2018) A study on characteristics of rheumatoid arthritis patients achieving remission in depression with 6 months of bDMARDs treatment. Eur J Rheumatol 5(2):111–114CrossRef
32.
go back to reference da Rocha Castelar-Pinheiro G, Vargas-Santos AB, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Resende Guimarães MFB, Bonfiglioli KR, Sauma MFLDC, Pereira IA, Brenol CV, Coutinho ESF, da Mota LMH (2018) The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil. Adv Rheumatol 58(1):9CrossRef da Rocha Castelar-Pinheiro G, Vargas-Santos AB, de Albuquerque CP, Bértolo MB, Júnior PL, Giorgi RDN, Radominski SC, Resende Guimarães MFB, Bonfiglioli KR, Sauma MFLDC, Pereira IA, Brenol CV, Coutinho ESF, da Mota LMH (2018) The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil. Adv Rheumatol 58(1):9CrossRef
33.
go back to reference Tundia N, Kotze PG, Rojas Serrano J, Mendes de Abreu M, Skup M, Macaulay D, Signorovitch J, Chaves L, Chao J, Bao Y (2016) Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn's disease in Argentina, Brazil, Colombia, and Mexico. J Med Econ 19(12):1187–1199CrossRef Tundia N, Kotze PG, Rojas Serrano J, Mendes de Abreu M, Skup M, Macaulay D, Signorovitch J, Chaves L, Chao J, Bao Y (2016) Economic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn's disease in Argentina, Brazil, Colombia, and Mexico. J Med Econ 19(12):1187–1199CrossRef
34.
go back to reference Acurcio FA, Machado MA, Moura CS, Ferre F, Guerra AA Jr, Andrade EI, Cherchiglia ML, Rahme E (2016) Medication persistence of disease-modifying antirheumatic drugs and anti-tumor necrosis factor agents in a cohort of patients with rheumatoid arthritis in Brazil. Arthritis Care Res (Hoboken) 68(10):1489–1496CrossRef Acurcio FA, Machado MA, Moura CS, Ferre F, Guerra AA Jr, Andrade EI, Cherchiglia ML, Rahme E (2016) Medication persistence of disease-modifying antirheumatic drugs and anti-tumor necrosis factor agents in a cohort of patients with rheumatoid arthritis in Brazil. Arthritis Care Res (Hoboken) 68(10):1489–1496CrossRef
36.
go back to reference da Mota LM, Brenol CV, Palominos P, Pinheiro GR (2015) Rheumatoid arthritis in Latin America: the importance of an early diagnosis. Clin Rheumatol 34(Suppl 1):S29–S44CrossRef da Mota LM, Brenol CV, Palominos P, Pinheiro GR (2015) Rheumatoid arthritis in Latin America: the importance of an early diagnosis. Clin Rheumatol 34(Suppl 1):S29–S44CrossRef
37.
go back to reference Gomes RKS, de Linhares AC, Lersch LS (2018) Prevalence and factors associated with diagnosis of early rheumatoid arthritis in the south of Brazil. Adv Rheumatol. 58(1):35CrossRef Gomes RKS, de Linhares AC, Lersch LS (2018) Prevalence and factors associated with diagnosis of early rheumatoid arthritis in the south of Brazil. Adv Rheumatol. 58(1):35CrossRef
38.
go back to reference Das Chagas Medeiros MM, Ferraz MB, Quaresma MR (2000) The effect of rheumatoid arthritis on the quality of life of primary caregivers. J Rheumatol 27(1):76–83PubMed Das Chagas Medeiros MM, Ferraz MB, Quaresma MR (2000) The effect of rheumatoid arthritis on the quality of life of primary caregivers. J Rheumatol 27(1):76–83PubMed
39.
go back to reference Torres JL, Castro-Costa E, Mambrini JVM, Peixoto SWV, Diniz BSO, Oliveira C, Lima-Costa MF (2018) Depressive symptoms, emotional support and activities of daily living disability onset: 15-year follow-up of the Bambuí (Brazil) cohort study of aging. Cad Saude Publ 34(7):e00141917CrossRef Torres JL, Castro-Costa E, Mambrini JVM, Peixoto SWV, Diniz BSO, Oliveira C, Lima-Costa MF (2018) Depressive symptoms, emotional support and activities of daily living disability onset: 15-year follow-up of the Bambuí (Brazil) cohort study of aging. Cad Saude Publ 34(7):e00141917CrossRef
40.
go back to reference Reese JB, Somers TJ, Keefe FJ, Mosley-Williams A, Lumley MA (2010) Pain and functioning of rheumatoid arthritis patients based on marital status: is a distressed marriage preferable to no marriage? J Pain 11(10):958–964CrossRef Reese JB, Somers TJ, Keefe FJ, Mosley-Williams A, Lumley MA (2010) Pain and functioning of rheumatoid arthritis patients based on marital status: is a distressed marriage preferable to no marriage? J Pain 11(10):958–964CrossRef
41.
go back to reference Albano MG, Giraudet-Le Quintrec JS, Crozet C, d'Ivernois JF (2010) Characteristics and development of therapeutic patient education in rheumatoid arthritis: analysis of the 2003-2008 literature. Joint Bone Spine 77(5):405–410CrossRef Albano MG, Giraudet-Le Quintrec JS, Crozet C, d'Ivernois JF (2010) Characteristics and development of therapeutic patient education in rheumatoid arthritis: analysis of the 2003-2008 literature. Joint Bone Spine 77(5):405–410CrossRef
Metadata
Title
Impact of clinical and psychological factors associated with depression in patients with rheumatoid arthritis: comparative study between Germany and Brazil
Authors
Harriet Morf
Geraldo da Rocha Castelar-Pinheiro
Ana Beatriz Vargas-Santos
Christoph Baerwald
Olga Seifert
Publication date
01-05-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 5/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05470-0

Other articles of this Issue 5/2021

Clinical Rheumatology 5/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.